PMID: 22329103Feb 15, 2012Paper

Dabigatran versus warfarin for patients with non-valvular atrial fibrillation: is the patient the winner?

The Australian Nursing Journal : ANJ
Sharon Grave

Abstract

The results of the RE-LY trial, the largest stroke prevention trial to date, have shown dabigatran to be the first oral anticoagulant with safety and efficacy comparable to warfarin. However, not all patients will be suitable candidates for treatment with dabigatran and much is yet to be learned of its results in long term use in real world applications. If as predicted, dabigatran becomes a serious contender to warfarin, nurses in almost all clinical settings will soon care for patients prescribed dabigatran; a potent anticoagulant for which there is no antidote.

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.